Biotechnology Innovation Organization (Formerly Biotechnology Industry Org.)
Represent organizations that promote research and support growth of biotechnology industry
Based in DC
AI Overview
With $2.2M in lobbying spend across 33 quarterly filings, Biotechnology Innovation Organization (Formerly Biotechnology Industry Org.) is a significant lobbying presence. They deploy 16 individual lobbyists Their lobbying covers 5 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $240K |
| 2019 | $290K |
| 2020 | $280K |
| 2021 | $360K |
| 2022 | $250K |
| 2023 | $200K |
| 2024 | $290K |
| 2025 | $290K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Biotechnology Innovation Organization (Formerly Biotechnology Industry Org.) disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Health Issues, Taxation, Trade, Budget/Appropriations
Medicare Part B Coverage and Reimbursement issues, including issues related to the Medicare Part D Coverage.
Patient access to biotechnology treatments.
Legislative issues related to the implementation of tax reform.
Medicare Parts B and coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.